<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101592634</journal-id>
<journal-id journal-id-type="pubmed-jr-id">41011</journal-id>
<journal-id journal-id-type="nlm-ta">J Pediatr Epilepsy</journal-id>
<journal-id journal-id-type="iso-abbrev">J Pediatr Epilepsy</journal-id>
<journal-title-group>
<journal-title>Journal of pediatric epilepsy</journal-title>
</journal-title-group>
<issn pub-type="ppub">2146-457X</issn>
<issn pub-type="epub">2146-4588</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27595042</article-id>
<article-id pub-id-type="pmc">5004990</article-id>
<article-id pub-id-type="doi">10.1055/s-0035-1567853</article-id>
<article-id pub-id-type="manuscript">NIHMS780663</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>SCN2A-Related Early-Onset Epileptic Encephalopathy Responsive to Phenobarbital</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Baumer</surname>
<given-names>Fiona M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peters</surname>
<given-names>Jurriaan M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>El Achkar</surname>
<given-names>Christelle M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pearl</surname>
<given-names>Phillip L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Neurology, Boston Children’s Hospital, Boston, Massachusetts, United States</aff>
<aff id="A2"><label>2</label>Division of Epilepsy, Department of Neurology, Boston Children’s Hospital, Boston, Massachusetts, United States</aff>
<author-notes>
<corresp id="FN1">Address for correspondence: Fiona M. Baumer, MD, Department of Neurology, Boston Children’s Hospital, 300 Longwood Avenue, Fegan 11, Boston, MA 02115, United States, <email>fbaumer@stanford.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>25</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2017</year>
</pub-date>
<volume>5</volume>
<issue>1</issue>
<fpage>42</fpage>
<lpage>46</lpage>
<!--elocation-id from pubmed: 10.1055/s-0035-1567853-->
<self-uri xlink:href="https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0035-1567853.pdf"></self-uri>
<abstract>
<p id="P1">Voltage-gated sodium channels (Nav) are critical regulators of neuronal excitability. Genes for the α-subunits of three sodium channel subtypes—SCN1A, SCN2A, and SCN3A—are all located on chromosome 2q24. A full-term boy with an unremarkable birth history presented at 1 month of age with unusual movements that had started on day of life 2. Exam was notable for lack of visual attention, hypotonia, and hyperreflexia. Electroencephalogram (EEG) showed an invariant burst suppression with multifocal spikes, ictal episodes with bicycling movements associated with buildups of rhythmic activity, and epileptic spasms. Work-up revealed a 1.77-Mb duplication at locus 2q24.3, encompassing the entirety of SCN2A and SCN3A, but not SCN1A. Phenobarbital led to rapid resolution of the clinical seizures and EEG background normalized other than rare sharp waves. Early-onset epileptic encephalopathy (EOEE), with neonatal seizures, burst suppression, and reversibility with phenobarbital, is part of the enlarging spectrum of Nav channelopathies. The delayed diagnosis provided an unusual opportunity to view the early natural history of this disorder and its remarkable responsiveness to barbiturate therapy. The clinical and EEG response to phenobarbital implicates seizures as the cause of the encephalopathy.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>